1. Zhu, N., et al. A Novel Coronavirus from Patients with Pneumonia in China. N Engl J Med. 382(8):727-733 (2020).
2. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).
3. Johns Hopkins University. Coronavirus Resource Center. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) https://coronavirus.jhu.edu/map.html (2021).
4. World Health Organization. WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/ (2021).
5. Robert Koch Institute. Empfehlungen zum Umgang mit SARS-CoV-2-infizierten Verstorbenen https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Verstorbene.html (2021).
6. Puelles, V.G., et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 383 (6): 590-592; 10.1056/NEJMc2011400 (2020).
7. Wichmann, D., et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 173 (4): 268-277 (2020).
8. Edler, C., et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, German. Int J Legal Med. 134 (4): 1275-1284 (2020).
9. Robert Koch Institute. COVID-19-Dashboard. https://experience.arcgis.com/experience/478220a4c454480e823b17327b2bf1d4/page/page_0/ (2021).
10. Statistisches Bundesamt Deutschland. Sterbefälle - Fallzahlen nach Tagen, Wochen, Monaten, Altersgruppen, Geschlecht und Bundesländern für Deutschland 2016 – 2021 https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Sterbefaelle-Lebenserwartung/Tabellen/sonderauswertung-sterbefaelle.html (2021).
11. Statista Research Department. Anzahl der Sterbefälle in Hamburg von 1991 bis 2020. https://de.statista.com/statistik/daten/studie/589257/umfrage/anzahl-der-sterbefaelle-in-hamburg/ (2021).
12. Fitzek, A., et al. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death. Rechtsmedizin. 1-6 (2020).
13. Sperhake, J.P. Autopsies of COVID-19 deceased? Absolutely!. Leg Med. 47: 101769; 10.1016/j.legalmed.2020.101769 (2020).
14. Yang, X., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 8 (5):475-481 (2020).
15. Liu, Y., et al. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J. 55 (5): 2001112; 10.1183/13993003.01112-2020 (2020).
16. Klein, S.L., et al. Biological sex impacts COVID-19 outcomes. PLoS Pathog. 16 (6): e1008570; 10.1371/journal.ppat.1008570 (2020).
17. Gebhard, C., et al. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 11 (1): 29 (2020).
18. Chen, T., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 368: m1091; 10.1136/bmj.m1091 (2020).
19. Borghesi, A., et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Med. 125 (5): 461-464 (2020).
20. Rommel, A., et al. The COVID-19 Disease Burden in Germany in 2020—Years of Life Lost to Death and Disease Over the Course of the Pandemic. Dtsch Arztebl Int. 118: arztebl.m2021.0147; 10.3238/arztebl.m2021.0147 (2021).
21. Stefan, N., Birkenfeld, L., Schulze, M.B. & Ludwig, D.S. Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. 16 (7): 341-342 (2020).
22. Petrilli, C.M., et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 369: m1966; 10.1136/bmj.m1966 (2020).
23. Simonnet, A., et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 28 (7): 1195-1199 (2020).
24. World Health Organization. Prevalence of obesity among adults, BMI ≥ 30 https://www.who.int/data/gho/indicator-metadata-registry/imr-details/2389 (2021).
25. Lax, S.F., et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med. 173 (5): 350-361 (2020).
26. Elezkurtaj, S., et. al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep. 11 (1): 4263 (2021).
27. Sungnak, W., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 26 (5): 681-687 (2020).
28. Elsoukkary, S.S., et al. Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience. Pathobiology. 88 (1): 56-68 (2021).
29. Kniep, I., et al. Postmortale Bildgebung der Lunge bei COVID-19-Todesfällen [Postmortem imaging of the lung in cases of COVID-19 deaths]. Radiologe. 60 (10): 927-933 (2020).
30. Matschke, J., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19 (11): 919-929 (2020).
31. Lindner, D., et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 5 (11): 1281-1285 (2020).
32. Kaltschmidt, B., et al. Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19. Clin Gastroenterol Hepatol. 1542-3565 (21) 00094-X; 10.1016/j.cgh.2021.01.044 (2021).
33. Renu, K., Prasanna, P.L. & Valsala Gopalakrishnan, A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review. Life Sci. 255: 117839; 10.1016/j.lfs.2020.117839 (2020).
34. Braun, F., et al. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. 396 (10251): 597-598 (2020).
35. Casagrande, M., et al. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol. 10.1136/bjophthalmol-2020-318618 (2021).
36. Casagrande, M., et al. Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19. JAMA Ophthalmol. 139(4): 383-388 (2021).
37. Püschel, K., et al. New developments and possibilities in the field of post-mortem medicine mortui vivos docent. Rechtsmedizin. 30, 425–429 (2020).
38. Busse, R.N. & Nimptsch, U. COVID-19-Pandemie: Historisch niedrige Bettenauslastung. Dtsch Arztebl. 118 (10): A-504 / B-426 (2020).
39. Statistisches Bundesamt Deutschland. Bevölkerungspyramide: Altersstruktur Deutschlands 1950 bis 2060. https://service.destatis.de/bevoelkerungspyramide/#!y=2029&a=20,80&g (2021).
40. Püschel, K. & Äpfelbacher, M. Umgang mit Corona-Toten: Obduktionen sind keinesfalls obsolet. Dtsch Arztebl Int. 117 (20): A-1058 / B-892 (2020).
41. Kommoss, F.K.F., et al. The Pathology of Severe COVID-19-Related Lung Damage. Dtsch Arztebl Int. 117 (29-30): 500-506 (2020).
42. Shojania, K.G., Burton E.C. The vanishing nonforensic autopsy. N Engl J Med. 358 (9): 873-875 (2008).
43. Turnbull, A., Osborn, M. & Nicholas N. Hospital autopsy: Endangered or extinct?. J Clin Pathol. 68 (8): 601-604 (2015).
44. Burton, J.L. & Underwood, J. Clinical, educational, and epidemiological value of autopsy. Lancet. 369 (9571): 1471-1480 (2007).
45. Blokker, B.M., Weustink, A.C., Hunink, M.G.M. & Oosterhuis, J.W. Autopsy rates in the Netherlands: 35 years of decline. PLoS One. 12(6): e0178200; 10.1371/journal.pone.0178200 (2017).
46. Roberts, W.C. The autopsy: its decline and a suggestion for its revival. N Engl J Med. 299 (7): 332-338 (1978).
47. Roberts, I.S., et al. Post-mortem imaging as an alternative to autopsy in the diagnosis of adult deaths: a validation study. Lancet. 379 (9811): 136-142 (2012).
48. Westphal, S.E., et al. Virtual CT autopsy in clinical pathology: feasibility in clinical autopsies. Virchows Arch. 461(2): 211-219 (2012).
49. Wichmann, D., et al. Virtual autopsy as an alternative to traditional medical autopsy in the intensive care unit: a prospective cohort study. Ann Intern Med. 156 (2): 123-130 (2012).
50. Cox, J.A., et al. Needle autopsy to establish the cause of death in HIV-infected hospitalized adults in Uganda: a comparison to complete autopsy. J Acquir Immune Defic Syndr. 67 (2): 169-176 (2014).
51. Castillo, P., et al. Pathological Methods Applied to the Investigation of Causes of Death in Developing Countries: Minimally Invasive Autopsy Approach. PLoS One. 10 (6): e0132057. 10.1371/journal.pone.0132057 (2015).
52. Martínez, M.J., et al. Infectious cause of death determination using minimally invasive autopsies in developing countries. Diagn Microbiol Infect Dis. 84 (1): 80-86 (2016).
53. Castillo, P., et al. Validity of a Minimally Invasive Autopsy for Cause of Death Determination in Adults in Mozambique: An Observational Study. PLoS Med. 13 (11): e1002171; 10.1371/journal.pmed.1002171 (2016).
54. Bassat, Q., et al. Validity of a minimally invasive autopsy tool for cause of death determination in pediatric deaths in Mozambique: An observational study. PLoS Med. 14 (6): e1002317; 1371/journal.pmed.1002317 (2017).
55. Fariña, J., et al. Ultrasonographic autopsy (echopsy): a new autopsy technique. Virchows Arch. 440 (6): 635-639 (2002).
56. Castillo, P., et al. Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study. PLoS Med. 14 (11): e1002431; 10.1371/journal.pmed.1002431(2017).
57. Bassat, Q., et al. Development of a post-mortem procedure to reduce the uncertainty regarding causes of death in developing countries. Lancet Glob Health. 1 (3): e125-e126; 10.1016/S2214-109X(13)70037-8 (2013).
58. Pfefferle, S., Reucher, S., Nörz, D. & Lütgehetmann, M. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Euro Surveill. 25 (9): 2000152 (2020).